Kenvue Health (KVUE) - Koefisien utang jangka dawa marang modal

Kenvue Health - logo grafis emiten KVUE

Kenvue Inc. (KVUE) relies on a powerful foundation of hygiene and pharmacy products spun off from J&J, which guarantees high business resilience. The price action of the securities reflects dynamics at the 0.65 metric value, as the company strives for profit growth and cost optimization. The popularity of brands such as Listerine and Tylenol ensures unconditional customer loyalty worldwide.

Kenvue Inc (KVUE): Utang jangka dawa marang ekuitas saka 21.02.2024 nganti 30.10.2026
Produk mawa merek Kenvue Inc.

Steady demand for Tylenol and Band-Aid brands allows Kenvue Inc. (KVUE) to manage capital effectively even amid rising marketing costs. By analyzing the ratio of long-term debt to net assets, an investor can see the proportion of liabilities with a maturity of over one year within the equity structure, which determines the business's reliance on borrowed funds and the issuer's overall financial stability.

Analisis perusahaan pesaing

Haleon PLC - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal VRNA|MENS (Jyong Bio) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal LGND (Ligand Pharmaceuticals)|Utang jangka dawa marang modal amneal.com AMRX|PRGO - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Utang jangka dawa marang modal|Utang jangka dawa marang modal mannkindcorp.com|Rasio utang jangka dawa marang ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Kewajiban jangka dawa marang modal|AQST: Rasio utang jangka dawa marang ekuitas|scPharmaceuticals Inc. - Rasio silihan jangka dawa marang modal|TECX: Utang jangka dawa marang modal|Tonix Pharma - Koefisien utang jangka dawa marang modal|SXTC (SXT Pharmaceuticals) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Eupraxia Pharma EPRX|Utang jangka dawa marang ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Oramed Pharmaceuticals Inc. ORMP|Utang jangka dawa marang modal Entera Bio Ltd ENTX|MindWalk - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal ABVC BioPharma, Inc|Cumberland Pharmaceuticals (CPIX) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal QNTM|Rasio utang jangka dawa marang ekuitas FGEN|Utang jangka dawa marang ekuitas TELO|Rasio utang jangka dawa marang ekuitas RANI (Rani Therapeutics)|Utang jangka dawa marang modal synergychc.com (SNYR)|Utang jangka dawa marang modal RLYB (Rallybio)|Lexaria Bioscience Corp (LEXX) - Kewajiban jangka dawa marang modal|PULM: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal PTHL (Pheton Holdings Ltd)|APM: Utang jangka dawa marang modal|LYRA - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Impact BioMedical Inc|Rasio utang jangka dawa marang modal TNFA (TNF Pharma)|Utang jangka dawa marang modal YCBD|Rasio utang jangka dawa marang ekuitas PainReform Ltd PRFX|Altamira Therapeutics Ltd. - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Lipella Pharma (LIPO)|OPTN - Utang jangka dawa marang ekuitas|PIRS - Utang jangka dawa marang modal|PROC (Procaps) - Rasio utang jangka dawa marang ekuitas|PTPI (Petros Pharmaceuticals Inc) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas QLI|Utang jangka dawa marang modal ACELYRIN Inc.|Utang jangka dawa marang modal TFFP